More Inoviq Ltd news
Inoviq LtdASX: IIQ

Ovarian Cancer Test Validation

Apr 18, 2024 at 11:02 PM EDT · Issued by Inoviq Ltd

Filed with ASX · Apr 18, 2024 at 11:02 PM EDT

On 6ix: 6ix.com/news/ovarian-cancer-test-validation

Inoviq Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Inoviq Ltd on 6ix

Earlier from Inoviq

  • INOVIQ Investor UpdateApr 17, 2024
  • INOVIQ and Promega sign Global EXO-NET AgreementApr 15, 2024
  • Appendix 4D and FY24 Half Year Financial ReportFeb 22, 2024
  • INOVIQ detects 19% more breast cancers than leading testFeb 22, 2024
  • Appendix 4C and Quarterly Activities Report - December 2023Jan 30, 2024

Later from Inoviq

  • Quarterly Activities Report and Appendix 4C - March 2024Apr 30, 2024
  • Breakthrough Exosome TherapyJun 2, 2024
  • INOVIQ completes $7m placementJun 12, 2024
  • INOVIQ isolates brain-derived exosomes in Alzheimer'sJun 12, 2024
  • INOVIQ lodges SPP and Options ProspectusJun 18, 2024
All Inoviq news releases↗

Follow Inoviq into a list and get an email when it puts out news.

Follow Inoviq
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer